SER
Serina Therapeutics Inc
NYSE MKT: SER · HEALTHCARE · BIOTECHNOLOGY
$1.83
-1.08% today
Updated 2026-04-29
Market cap
$27.26M
P/E ratio
—
P/S ratio
209.73x
EPS (TTM)
$-1.91
Dividend yield
—
52W range
$1 – $8
Volume
4.0M
Serina Therapeutics Inc (SER) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | $3.22M | $9.63M | $10.67M | $7.44M | $3.92M | $3.15M | $3.24M | $8.97M | $6.72M |
| Cash & equivalents | $259000.00 | $7.38M | $6.71M | $2.35M | $527000.00 | $584000.00 | $645000.00 | $7.62M | $3.67M |
| Current assets | $688000.00 | $7.59M | $7.85M | $4.05M | $2.28M | $2.23M | $2.45M | $7.62M | $5.68M |
| Total liabilities | $25.60M | $1.31M | $2.44M | $4.83M | $9.32M | $15.03M | $20.56M | $41.26M | $6.22M |
| Current liabilities | $25.60M | $1.31M | $2.44M | $3.30M | $5.36M | $8.97M | $10.08M | $1.41M | $2.37M |
| Long-term debt | — | — | — | — | — | — | $1.62M | $2.98M | $0.00 |
| Shareholder equity | $-23.42M | $7.28M | $7.45M | $2.22M | $-5.12M | $-11.83M | $-17.21M | $-32.29M | $641000.00 |
| Retained earnings | $-59.97M | $-66.55M | $-74.05M | $-86.21M | $-97.07M | $-105.75M | $-116.21M | $-33.18M | $-44.32M |
| Accounts receivable | $308000.00 | $107000.00 | $131000.00 | $363000.00 | $326000.00 | $25000.00 | $4000.00 | $57000.00 | — |
| Inventory | — | — | — | — | — | $-1.61M | $-1.79M | — | — |
| Goodwill | — | — | — | — | — | — | — | — | — |